Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism: a Multicenter Randomized Placebo-controlled Non-inferiority Trial

NCT04263038 is registered in ClinicalTrials.gov with Drahomir Aujesky as lead sponsor.

NCT NCT04263038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04263038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism: a Multicenter Randomized Placebo-controlled Non-inferiority Trial
Lead sponsor
Drahomir Aujesky
Phase
Phase 4
Overall status
Recruiting
Start date
May 15, 2020
Completion date
May 31, 2028
Enrollment
276 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant-induced bleeding, bleeding, cardiovascular diseases, embolism, embolism and thrombosis, lung diseases, pulmonary embolism, respiratory tract diseases, venous thromboembolism